Prospective Observational Study on Stelara Assessing Efficacy and Healthcare Resource Utilization in Crohn's Disease (PROSE)

Trial Profile

Prospective Observational Study on Stelara Assessing Efficacy and Healthcare Resource Utilization in Crohn's Disease (PROSE)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Apr 2018

At a glance

  • Drugs Ustekinumab (Primary)
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Acronyms PROSE
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 16 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top